HOME >> BIOLOGY >> NEWS
InHealth awards two research grants to Stanford University

Washington, D.C., October 13, 2006 -The Institute for Health Technology Studies (InHealth) has awarded one-year research grants to two teams at Stanford University. One will examine the socio-economic value of MRI and CT imaging technology. The other will document the current regulatory and commercialization processes required of new medical technologies. The grants, totaling $538,207, are part of InHealth's continuing research mission to bring objective data and perspective to understanding the impact of medical technology on patients and the health care industry.

The first study, "The Diffusion of Imaging Technologies, Health Care Costs and Quality," will investigate the relationships among the availability of advanced diagnostic imaging services, usage, patient outcomes and health care spending. The second study, "Medical Device Development Models," will document how medical devices are approved and enhanced, pre- and post-market, including the role of the Food and Drug Administration. In addition, the study will clarify the different paths followed by medical devices, pharmaceuticals and biotech products. Results from both studies are anticipated by fall 2007.

"Critical discussions about the nation's health care system should be based on objective data rather than political opinion. Our goal is to help uncover that data so that decision-makers have a fuller understanding of how to legislate and regulate in the health and economic interests of patients and their families," said Martyn Howgill, Executive Director of InHealth.

Examining the Growth and Impact of Advanced Imaging Technologies

Stanford investigators will look at the effects of increased availability of MRI and CT technologies on the cost and quality of health care and whether costs are offset by benefits. No such studies are currently available. The researchers will collect data from 1992-2004 on the availability of MRI and CT services in differe
'"/>

Contact: Robyn Stein
Robyn.Stein@gabbe.com
212-220-4444
Innsbruck Medical University
13-Oct-2006


Page: 1 2 3

Related biology news :

1. Argonne wins three R&D 100 awards for innovative technologies
2. ASBMB taps 8 scientists and 1 politician for top awards
3. 2007 EURYI: 20 young researchers to receive Nobel Prize-sized awards for breakthrough ideas
4. US Department of Defense awards $1.6 million for implantable biochip research
5. 20 Kentucky firms share $1.9 million from state to match federal SBIR-STTR awards
6. The Cancer Genome Atlas awards funds for technology development
7. NIH awards nearly $21 million to fund cutting-edge research equipment
8. SNM presents awards on Capitol Hill
9. National awards for 2 University of York scientists
10. Burroughs Wellcome Fund awards $14M to support physician-scientists
11. NIH awards VBI, Mayo Clinic $2.4M to study chronic rhinosinusitis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2020)... ... April 27, 2020 , ... ... was started by three teenagers with an idea to help millions of people ... the time of great need and suffering, an outlet has been created for ...
(Date:4/22/2020)... ... April 20, 2020 , ... RCH Solutions (RCH ), a global ... announces the hiring of Michael Wlodarczyk as Director of Sales and Business Development. Based ... grow the company’s already strong presence across the Northeast. , “We continue to see ...
(Date:4/18/2020)... ... April 16, 2020 , ... SIRION Biotech GmbH , a world ... it will present a company update on its work expediting gene therapy research and ... on April 22 and 23. Dieter Lingelbach, the Company’s Chief Operating Officer, will also ...
Breaking Biology News(10 mins):
(Date:4/26/2020)... ... April 23, 2020 , ... Indegene Omnipresence, Inc. ... providing applications and services for use on Microsoft Azure. The customer experience management ... up online for a built-for-purpose customer engagement capability to use in their commercial ...
(Date:4/22/2020)... and CAMBRIDGE, Mass. (PRWEB) , ... April 20, ... ... Budapest with US offices in Cambridge, MA, announced today that Omixon’s founder and ... the early commercialisation of Omixon’s flagship product Holotype HLA since 2014 before stepping ...
(Date:4/22/2020)... ... April 21, 2020 , ... ... work through COVID-19. Many clinical trial teams are working remotely and have paused ... wants to help researchers continue their research during this uncertain time by giving ...
(Date:4/7/2020)... ... April 06, 2020 , ... Gateway Genomics , leading developer ... SneakPeek Early Gender DNA Tests sold in March, just months after attaining ... an ecommerce product, where a mom could order her kit online, collect a DNA ...
Breaking Biology Technology:
Cached News: